Back to Newsroom
Back to Newsroom

LEGAL INVESTIGATION ALERT: Halper Sadeh LLP Announces It is Investigating Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - MYOS, REXN

Friday, 03 July 2020 02:50 AM

Halper Sadeh LLP

Topic:
Lawsuits

NEW YORK, NY / ACCESSWIRE / July 3, 2020 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating whether the following mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders:

Halper Sadeh LLP, Friday, July 3, 2020, Press release picture

MYOS RENS Technology Inc. (NASDAQ: MYOS)

The investigation concerns whether MYOS RENS Technology Inc. and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection with the merger between MYOS RENS Technology Inc. and MedAvail, Inc. Following the merger, MYOS RENS shareholders will own approximately 3.5% of the combined company and MedAvail's security holders and new investors will own approximately 96.5% of the combined company (on a fully diluted basis). If you are a MYOS RENS shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/myos-rens-technology-inc-myos-stock-merger-medavail/.

Rexahn Pharmaceuticals, Inc. (NASDAQ: REXN)

The investigation concerns whether Rexahn Pharmaceuticals and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders in connection the merger between Rexahn Pharmaceuticals and Ocuphire Pharma, Inc. If you are a Rexahn Pharmaceuticals shareholder and would like to learn more about your legal rights and options, please visit: https://halpersadeh.com/actions/rexahn-pharmaceuticals-inc-rexn-stock-merger-ocuphire/.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP

Daniel Sadeh, Esq.

Zachary Halper, Esq.

(212) 763-0060

[email protected]

[email protected]

https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP

Topic:
Lawsuits
Back to newsroom
Back to Newsroom
Share by: